Genetic Polymorphisms of Peroxisome Proliferator-Activated Receptors and the Risk of Cardiovascular Morbidity and Mortality in a Community-Based Cohort in Washington County, Maryland

Abstract EN

The primary aim of this study was to examine prospectively the associations between 5 peroxisome proliferator-activated receptor (PPAR) single nucleotide polymorphisms (SNPs) and cardiovascular morbidity and mortality in a community-based cohort study in Washington County, Maryland.

Data were analyzed from 9,364 Caucasian men and women participating in CLUE-II.

Genotyping on 5 PPAR polymorphisms was conducted using peripheral DNA samples collected in 1989.

The followup period was from 1989 to 2003.

The results showed that there were no statistically significant associations between the PPAR SNPs and cardiovascular deaths or events.

In contrast, statistically significant age-adjusted associations were observed for PPARG rs4684847 with both baseline body mass and blood pressure, and for PPARG rs709158, PPARG rs1175543, and PPARD rs2016520 with baseline cholesterol levels.

Future studies should be conducted to confirm these findings and to explore the associations in populations with greater racial and ethnic diversity.